25 May 2013
Keywords: roche, actemra, improves, ra, symptoms, swiss, drug
Article | 25 June 2007
Swiss drug major Roche has reported positive results from the OPTION trial, the first rheumatoid arthritis multinational Phase III study ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 June 2007
24 May 2013
© 2013 thepharmaletter.com